Hillary Clinton’s prescription to soothe the economic hangover consumers have from ObamaCare’s regulatory binge is a single ingredient: more regulation. Mrs. Clinton begins her treatment plan by focusing on “price gouging” by pharmaceutical companies and the need for price regulation.
ObamaCare Watch
A Project of the Galen Institute
A Clintonian Misdirection on Drug Prices
You are here:
